International Alliance for Biological Standardization

Select Page


Evolution of FMT

From Early Clinical to Standardized Treatments

May 21, 2021
Virtual Meeting



Autogenous Vaccines Meeting

Quality of Production and Movement in a Common Market

September 14-16, 2021
Munich, Germany

Register now

7th IABS Statistics Workshop

Accelerating Drug Development: How QbD, Regulatory Partnerships, and Pandemic Learning Can Further Expedite Meeting Patient Needs

November 8-11, 2021

Learn more & Register now

Maintening the Quality of Vaccines through the Use of References Standards Current Challenges and Future Opportunities

June, 2022

Learn more & Register now

Cross Learning Experience Human and Animal Vaccine Licensure based on Technology Platforms

Learn more & Register now


Discover IABS with Joris Vandeputte

In this short interview, Joris Vandeputte, President of IABS has answered the question “Why support IABS?”
To learn more about the International Alliance for Biological…

Read more

Accelerating Global Deletion of the Abnormal Toxicity Test Virtual event

Objectives :
Building from the results of HSI Symposium (Rome, 2019) and on the IABS congress (Bangkok, 2019), bring together a wider but specific range of key international and…

Read more

IABS 7th Statistics Workshop - Vitual Meeting

The pharmaceutical industry, academicians, and global regulators have demonstrated over the past year that drug development can be incredibly accelerated to address urgent, unmet needs…

Read more



IMI is a European public-private partnership aiming to speed up the development of better and safer medicines. IMI is partly founded by the European Commission.

The IABS European Affiliate (IABS-EU) was part of consortia which have  been selected by IMI to be the public partners of following consortia.

IABS-EU was selected to drive the regulatory part of those consortia.


MANCO (Monclonal Antibodies against COVID-19) is one of the eighteen projects that have been successfully selected by the European Commission, which is devoted to the development of Monoclonal Antibodies agains COVID-19.

IABES-EU was selected to drive the regulatory part of the project


John Petricciani

Past President
Advisor to the Board

“ Cell substrates have been a key element in the evolution of biological products since the…

Read more

Kathryn Zoon

NIH Scientist Emeritus
Past NIAID Scientific Director

As a long term US regulator and scientist, I have been working with IABS for many years. The IABS has assiste…

Read more

Philippe Duclos

Director ADVAC
University of Geneva

“ A vibrant organization that allows dialogue beyond professional boundaries…

Read more

Timothy Schofield

Chair Publication

“ I am proud to be part of an organization that puts global public health first…

Read more